STOK - Financial Reports List - Stoke Therapeutics, Inc. - IntrinsicAlpha

Stoke Therapeutics, Inc. STOK

Healthcare - Biotechnology - NASDAQ - US

$ 8.92

12 %

$ 482 M

Market Cap

-5.22

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	707.07%	61.12%	53.85%
Annual Report	FY	10-K	2024-12-31	316.34%	15.01%	11.68%
Quarterly Report	Q3	8-K	2024-09-30	47.94%	-7.69%	-10.17%
Quarterly Report	Q2	8-K	2024-06-30	294.72%	16.18%	11.79%
Quarterly Report	Q1	8-K	2024-03-31	-18.17%	-44.14%	-38.79%
Quarterly Report	Q4	8-K	2023-12-31	-14.29%	-22.28%	-8.87%
Annual Report	FY	10-K	2023-12-31	-29.22%	-12.45%	-9.98%
Quarterly Report	Q3	8-K	2023-09-30	13.87%	-1.92%	-0.32%
Quarterly Report	Q2	8-K	2023-06-30	-76.79%	-32.02%	-31.79%
Quarterly Report	Q1	8-K	2023-03-31	71.73%	25.01%	17.56%

1